Shopping Cart
Remove All
Your shopping cart is currently empty
Antiviral agent 74
Catalog No. T214055 Copy Product Info
🥰Excellent
Antiviralagent 74 is an antiviral compound that consists of a Cidofovir prodrug linked to a lipid chain. After conversion to Cidofovir, Antiviralagent 74 inhibits the activity of viral DNA polymerase. It demonstrates potent antiviral activity against vaccinia virus (VACV) with an EC50 value of 0.156 μM, comparable to the activity of Brincidofovir. Its efficacy against monkeypox virus (MPXV) is even greater, with an EC50 value of 0.202 μM. Antiviralagent 74 is applicable in the study of viral infections.
Antiviral agent 74
Copy Product Info🥰Excellent
Catalog No. T214055
Antiviralagent 74 is an antiviral compound that consists of a Cidofovir prodrug linked to a lipid chain. After conversion to Cidofovir, Antiviralagent 74 inhibits the activity of viral DNA polymerase. It demonstrates potent antiviral activity against vaccinia virus (VACV) with an EC50 value of 0.156 μM, comparable to the activity of Brincidofovir. Its efficacy against monkeypox virus (MPXV) is even greater, with an EC50 value of 0.202 μM. Antiviralagent 74 is applicable in the study of viral infections.
Antiviral agent 74
Cas No. 3059641-72-1
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Antiviralagent 74 is an antiviral compound that consists of a Cidofovir prodrug linked to a lipid chain. After conversion to Cidofovir, Antiviralagent 74 inhibits the activity of viral DNA polymerase. It demonstrates potent antiviral activity against vaccinia virus (VACV) with an EC50 value of 0.156 μM, comparable to the activity of Brincidofovir. Its efficacy against monkeypox virus (MPXV) is even greater, with an EC50 value of 0.202 μM. Antiviralagent 74 is applicable in the study of viral infections. |
| In vitro | Antiviral agent 74 (Compound 13f) demonstrates potent antiviral activity against the vaccinia virus (VACV) and monkeypox virus (MPXV) in Vero cells, with EC50 values of 0.156 and 0.202 μM. Additionally, Antiviral agent 74 exhibits low cytotoxicity in Vero cells, with a CC50 value of 11.36 μM. |
| Molecular Weight | 623.79 |
| Formula | C28H54N3O8PS |
| Cas No. | 3059641-72-1 |
| Smiles | C([C@H](OCP(OCCS(CCCCCCCCCCCCCCCCCC)(=O)=O)(=O)O)CO)N1C(=O)N=C(N)C=C1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Citations
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Antiviral agent 74 | purchase Antiviral agent 74 | Antiviral agent 74 cost | order Antiviral agent 74 | Antiviral agent 74 in vitro | Antiviral agent 74 formula | Antiviral agent 74 molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.